Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Toxic shock syndrome is caused by a complex interaction of bacterial toxins and the immune system, and understanding this can help improve diagnosis and treatment.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Fibroblast and endothelial cell interactions are crucial in forming hypertrophic scars.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Secukinumab for psoriasis may cause hair loss.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Finasteride reduces some inflammation in BPH but not all.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Hidradenitis suppurativa is a chronic skin disorder linked to genetics, lifestyle, and immune issues, treatable with medications and surgery.

Hidradenitis suppurativa is a chronic skin disorder linked to genetics, lifestyle, and immune issues, treatable with medication and sometimes surgery.

Hair follicles play a crucial role in regulating skin barrier function.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Secukinumab effectively treated a difficult case of folliculitis decalvans.